Common Contracts
2 similar null contracts by CytoCore Inc
WARRANT TO PURCHASE SHARES OF COMMON STOCK ISSUE DATE: January 22, 2007CytoCore Inc • April 3rd, 2008 • Surgical & medical instruments & apparatus • Delaware
This certifies that Dr. Augusto Ocana, an individual resident of the State of New Jersey (the “Holder”), for value received, is entitled to purchase from CytoCore, Inc., a Delaware corporation with its principal business office located at 414 North Orleans Street, Suite 502, Chicago, Illinois 60610 (together with its successors and assigns, the “Company”), subject to the terms and conditions set forth below, at any time or from time to time on and after the Issue Date as set forth above and before 3:00 p.m. (Eastern Time) on January 22, 2010 (the “Expiration Date”), Five Hundred Thousand (500,000) shares of common stock, $.001 par value per share, of the Company (“Common Stock”), at a price per share of $0.20. The shares purchasable upon exercise of this Warrant, and the applicable purchase price per share, each as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter referred to as the “Warrant Shares” and the “Purchase Price,” respectively.
WARRANT TO PURCHASE SHARES OF COMMON STOCK ISSUE DATE: September 28, 2006CytoCore Inc • March 30th, 2007 • Surgical & medical instruments & apparatus • Delaware
This certifies that David J. Weissberg, M.D., an individual resident of New York State (or any valid transferee thereof, the “Holder”), for value received, is entitled to purchase from CytoCore, Inc., a Delaware corporation with its principal business office located at 414 North Orleans Street, Suite 502, Chicago, Illinois 60610 (together with its successors and assigns, the “Company”), subject to the terms and conditions set forth below, at any time or from time to time on and after the Issue Date as set forth above and before 3:00 p.m. (Eastern Daylight Time) on September 28, 2011 (the “Expiration Date”), Four Million (4,000,000) shares of common stock, $0.001 par value per share, of the Company (“Common Stock”), at a price of Twenty Cents ($0.20) per share. The shares purchasable upon exercise of this Warrant, and the purchase price per share, each as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter referred to as the “Warrant Shares” and the “P
